Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Early Low Rectal Cancer × spartalizumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 16 Neoplasm Metastasis 11 Nasopharyngeal Carcinoma 9 Melanoma 9 Carcinoma, Non-Small-Cell Lung 9 Pancreatic Neoplasms 7 Locally Advanced Rectal Cancer 7 Colorectal Neoplasms 7 Rectal Neoplasms 6 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Extranodal NK-T-Cell 3 Glioblastoma 3 Esophageal Neoplasms 3 Uterine Cervical Neoplasms 2 Solid Tumor 2 Prostatic Neoplasms 2 Nasopharyngeal Neoplasms 2 Lymphoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Gastrointestinal Stromal Tumors 2 Epstein-Barr Virus Infections 2 Cholangiocarcinoma 2 Breast Neoplasms 2 Advanced Solid Tumor 2 Urinary Bladder Neoplasms 1

Interventions

toripalimab 2 Oxaliplatin 2 Capecitabine 2 spartalizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05555888 2025-01-15

TORCH-E

Fudan University

Phase 2 Recruiting

Gastrointestinal

Early Low Rectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡